10 November 2021
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that across 5 and 8 November 2021, Kevin Havelock, a Non-Executive Director of the Company, bought, in aggregate, 7,630 ordinary shares in the Company at a volume weighted average price of GBP £24.89 per ordinary share via the London Stock Exchange.
Ends
For further information:
Investor queries
Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)743 582 8138
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024
Nominated Advisor and Joint Broker - Numis Securities
Garry Levin I Matt Lewis I Hugo Rubinstein I +44 (0)20 7260 1000
Joint Broker - Investec Bank plc
David Flin I Alex Wright I +44 (0)20 7597 5970
Financial PR advisers - Finsbury
Faeth Birch +44 (0)7768 943 171 I Chris Ryall +44 (0)7342 713 748 I Amanda Healy +44 (0)7795 051 635
Notes to Editors:
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||||||||||||||||||||||||
| a) | Name | Kevin Havelock | |||||||||||||||||||||||||||
| 2 | Reason for the notification | ||||||||||||||||||||||||||||
| a) | Position/status | Non-Executive Director | |||||||||||||||||||||||||||
| b) | Initial notification/Amendment | Initial Notification | |||||||||||||||||||||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||||||||||||||||
| a) | Name |
| |||||||||||||||||||||||||||
| b) | LEI | 2138007AJRLHRVQZLD07 | |||||||||||||||||||||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||||||||||||||
| a) | Description of the financial instrument, type of instrument Identification code |
| |||||||||||||||||||||||||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | |||||||||||||||||||||||||||
| c) | Price(s) and volume(s) |
| |||||||||||||||||||||||||||
| d) | Aggregated information
|
| |||||||||||||||||||||||||||
| e) | Date of the transaction | Across 5 and 8 November 2021 as described above | |||||||||||||||||||||||||||
| f) | Place of the transaction | London Stock Exchange | |||||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
